Mutation burden and other molecular markers of prognosis in colorectal cancer treated with curative intent: results from the QUASAR 2 clinical trial and an Australian community-based series
2018 · The Lancet. Gastroenterology & hepatology · 75 citations
https://doi.org/10.1016/s2468-1253(18)30117-1